Health
Qiming Venture Partners Nisa Leung and Duane Kuang Made the 2023 Forbes Midas List
SHANGHAI, May 5, 2023 /PRNewswire/ -- The 2023 Forbes Midas List, a prestigious industry list of world's best venture capital investors, was unveiled. Qiming Venture Partners Managing Partner Nisa Leung and Founding Managing Partner Duane Kuang made the list. The Midas List, which was launched i...
2023-05-05 21:08
3682
CARsgen's CLDN18.2 mAb AB011 Achieves IND Clearance from the NMPA for the First-line Combination Treatment of Gastric Cancer
SHANGHAI, May 5, 2023 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announced that AB011 in combination with atezolizumab monoclonal antibody, Roche'...
2023-05-05 20:50
3316
Health In Tech Revolutionizes Level-Funded Health Plans in Ohio through Partnership with Ohio PPO Connect
STUART, Fla., May 5, 2023 /PRNewswire/ -- Health in Tech, the industry-leading insurtech company that delivers disruptive innovation and reimagines self-funded health plans, proudly announces its accelerated implementation with Ohio PPO Connect, LLC. This strategic partnership aims to provide a ...
2023-05-05 20:30
2386
New report by the Global Hygiene Council (GHC) highlights critical role of hygiene in the fight against antimicrobial resistance and future pandemics
LONDON, May 5, 2023 /PRNewswire/ -- A new report launched today by the Global Hygiene Council (GHC), an independent council of leading experts in hygiene and infection prevention, calls for urgent action to prioritise hygiene in home and community settings in pandemic preparedness plans beyond CO...
2023-05-05 20:14
3228
Viva Biotech's Recent Conferences & Events Review
HONG KONG, May 5, 2023 /PRNewswire/ -- In April, Viva Biotech was invited to attend 2022 SAPA-China Annual Conference, 88th API China, Drug Discovery Chemistry, American Association for Cancer Research (AACR) Annual Meeting 2023, CPHI Japan 2023, PharmFuture 2023 Small Molecule Innovative Drug Fu...
2023-05-05 19:58
3981
ProQure and Identiv Partner to Launch Innovative NFC Type 2 Tags for Large-Scale NFC Deployments
The partnership's new PQ201/201s series tags deliver premium features at a competitive price point PLEASANTON, Calif., May 5, 2023 /PRNewswire/ -- ProQure, a technology provider of IoT cloud management for physical objects, and Identiv, a global leader in physical security and secure identificat...
2023-05-05 18:00
2464
Arbele celebrates its 7th anniversary as a clinical-stage immunotherapy biotech and the opening of TibTech, its cancer diagnostics subsidiary
SEATTLE, May 5, 2023 /PRNewswire/ -- Arbele, a biotechnology company dedicated to fighting gastrointestinal cancers, celebrates its 7th anniversary and the opening of Tiberias Technology (TibTech), its accredited lab for cancer screening and in vitro diagnostics, at the Hong Kong Science and Tech...
2023-05-05 15:00
1739
P&G Health commemorates Neuropathy Awareness Week 2023 with an effort to help people 'Put Life Back in Their Hands'
* Dons the purple ribbon for the 2nd consecutive year to raise awareness on Peripheral Neuropathy, a condition significantly underdiagnosed and undertreated inAsia, Middle East & Africa * Releases new research study highlighting the role of B Vitamins in supporting healthy nerve functions SIN...
2023-05-05 11:30
3651
Advanced Endoscopic Procedures: From Diagnosis to Minimally Invasive Treatments
SINGAPORE, May 5, 2023 /PRNewswire/ -- Endoscopy has come a long way since its inception in the mid-1800's. Various technological advancements within the realm of gastroenterology and hepatology have allowed the scope to reach deep-seated organs or examine long structures, like the intestines. "A...
2023-05-05 08:15
2522
Formosa Pharmaceuticals and AimMax Therapeutics Announce the NDA Submission to the US FDA for APP13007 for the Treatment of Post-Operative Inflammation and Pain following Ocular Surgery
TAIPEI, May 4, 2023 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. (6838.TWO) and AimMax Therapeutics, Inc. (United States) announce the submission of a New Drug Application to the United States Food & Drug Administration (US FDA) for APP13007, a novel aqueous nanosuspension formulation of the pot...
2023-05-05 08:00
1955
MedAlliance Enrolls First US Patient into its Third FDA IDE Study: SFA SELUTION4SFA
GENEVA, May 5, 2023 /PRNewswire/ -- The first US patient has been enrolled in the SELUTION4SFA Sirolimus DEB study by Dr.Arthur Lee at the Cardiac & Vascular Institute inFlorida. This study evaluates SELUTION SLR™ in the treatment of occlusive disease of the superficial femoral artery (SFA) and p...
2023-05-05 08:00
3273
Recall Notice - SD Biosensor, Inc. requests discontinuation of use and disposal of specific Pilot™ COVID-19 At-Home Tests in the United States due to microbial contamination in the liquid buffer solution
SEOUL, South Korea, May 4, 2023 /PRNewswire/ -- SD Biosensor, Inc. today is requesting that consumers stop using and dispose of specific Pilot COVID-19 At-Home Tests inthe United States because potentially harmful bacteria were found in the tube with liquid inside (pouch 2 of the kits). The affe...
2023-05-05 04:00
2160
ABM Announces First Patient Dosed in Phase I Clinical Trial of MEK Inhibitor for Solid Tumor
SAN DIEGO and SHANGHAI, May 4, 2023 /PRNewswire/ -- ABM Therapeutics, an innovative clinical-stage biopharmaceutical company, with an emphasis on developing drugs with high blood–brain barrier (BBB) penetration for CNS diseases including brain metastases, today announced that the first patient wa...
2023-05-05 01:00
2497
SNIPR Biome's data on first clinical drug candidate to prevent infections in hematological cancer patients published in Nature Biotechnology
* SNIPR001 is a novel CRISPR-Cas therapeutic designed to selectively target antibiotic resistantE. coli, which can cause fatal infections in vulnerable hematological cancer patients * SNIPR001 represents the first CRISPR- therapeutic developed to specifically removeE. coli in the ...
2023-05-05 00:52
2636
DetectedX's Radiology Online Learning Centre Passes 4,500 Users
DetectedX will Showcase New Interactive Educational Technology at SBI NATIONAL HARBOR, Md., May 4, 2023 /PRNewswire/ -- DetectedX, the leaders in intelligent interactive educational technology, announced today that it has surpassed 4,500 users of its Radiology Online Learning Centre. Users, whic...
2023-05-04 23:25
2217
National Comprehensive Cancer Network Honors Cancer Leaders who Guide the Future of Care
Theresa J. Franco, Fred & Pamela Buffett Cancer Center; F. Marc Stewart, City of Hope National Medical Center;Douglas E. Wood, UW Medicine Fred Hutchinson Cancer Center; andDonna Powell, NCCN, presented with awards during NCCN 2023 Annual Conference. PLYMOUTH MEETING, Pa., May 4, 2023 /PRNewswir...
2023-05-04 23:00
2624
ANGUS ANNOUNCES CORPORATE REBRANDING, WILL CHANGE NAME TO "ADVANCION"
New name and brand reflect Company's strategic transformation into a leading global producer of specialty ingredients for Life Sciences, Personal Care and other essential markets BUFFALO GROVE, Ill., May 4, 2023 /PRNewswire/ -- ANGUS Chemical Company ("ANGUS" or "Company") today unveiled a new n...
2023-05-04 21:00
3537
Cambridge Infinitus Research Centre Launches World Leading AI-based Technology Platform ERnet for Studies of Cellular Health
GUANGZHOU, China, May 4, 2023 /PRNewswire/ -- The Cambridge Infinitus Research Centre (CIRCE) was officially established in 2015 as Infinitus' first international scientific research collaboration platform outside ofChina. CIRCE recently achieved another scientific and technological breakthrough ...
2023-05-04 16:00
2829
Momcozy Mother's Day Deal: Choose America's Top-selling Wearable Breast Pump Chosen by 2 Million Moms
NEW YORK, May 4, 2023 /PRNewswire/ -- Momcozy, the #1 selling wearable breast
pump brand inNorth America, has announced a series of irresistible deals in
celebration of Mother's Day. SinceMay 4th , whether on Momcozy's website
2023-05-04 14:59
1909
First Subject Enrolled in Boan Biotech's International Multi-Center Phase 3 Clinical Study for Its Denosumab BA6101 & BA1102
YANTAI, China, May 4, 2023 /PRNewswire/ -- Boan Biotech today announced that an international multi-center Phase 3 clinical study for its in-house developed Denosumab Injection (BA6101; BA1102) has been initiated inEurope, the United States, and Japan, and recently the first patient in (FPI) was ...
2023-05-04 14:40
3974
Week's Top Stories
Most Reposted
Thailand Tops 2024 Consumer Review Awards by Agoda
[Picked up by 329 media titles]
2024-09-26 11:00
WARHAMMER 40,000: SPACE MARINE VR - DEFENDERS OF AVARAX NOW AVAILABLE AT ZERO LATENCY VR VENUES WORLDWIDE
[Picked up by 314 media titles]
2024-09-26 00:00
Advantech Unveils Expanded Singapore Office to Boost ASEAN Presence and Support AIoT Innovations with Strategic Partnerships
[Picked up by 312 media titles]
2024-09-23 13:37
Circles Partners with Telkomsel, Providing an Advanced Software-as-a-Service (SaaS) Platform to Enhance Customer Digital Experience
[Picked up by 297 media titles]
2024-09-27 10:00RuggON Debuts at the Largest Mining Expo, MINExpo 2024 Showcasing Rugged Solutions for the Trillion-Dollar Mining Market
[Picked up by 294 media titles]
2024-09-23 22:00
Most Read
RuggON Debuts at the Largest Mining Expo, MINExpo 2024 Showcasing Rugged Solutions for the Trillion-Dollar Mining Market
2024-09-23 22:00
6933
WARHAMMER 40,000: SPACE MARINE VR - DEFENDERS OF AVARAX NOW AVAILABLE AT ZERO LATENCY VR VENUES WORLDWIDE
2024-09-26 00:00
6853
Advantech Unveils Expanded Singapore Office to Boost ASEAN Presence and Support AIoT Innovations with Strategic Partnerships
2024-09-23 13:37
6316
Thailand Tops 2024 Consumer Review Awards by Agoda
2024-09-26 11:00
5639
Sobot Reflects on its Partnership with Lilith Games on Lilith's 11th Anniversary
2024-09-24 10:00
5543
